Evidence map›Paper›PMID 33008033›Full record

ArticleInternational journal of molecular sciences2020

Protective Effects of Simvastatin on Endotoxin-Induced Acute Kidney Injury through Activation of Tubular Epithelial Cells' Survival and Hindering Cytochrome C-Mediated Apoptosis.

Lana Nežić, Ranko Škrbić, Ljiljana Amidžić, Radoslav Gajanin, Zoran Milovanović, Eugenie Nepovimova, Kamil Kuča, Vesna Jaćević

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Advances in Nano-Immunomodulatory Systems for the Treatment of Acute Kidney Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Review
  8. Article
  9. Roles of SIRT3 in aging and aging-related diseases.International journal of biological sciences · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Lana NežićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, School of Medicine, University of Banja Luka, 14 Save Mrkalja St, 78000 Banja Luka, Bosnia and Herzegovina.ORCID 0000-0002-4217-5437
Ranko ŠkrbićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, School of Medicine, University of Banja Luka, 14 Save Mrkalja St, 78000 Banja Luka, Bosnia and Herzegovina.
Ljiljana AmidžićCenter for Biomedical Research, School of Medicine, University of Banja Luka, 14 Save Mrkalja St, 78000 Banja Luka, Bosnia and Herzegovina.
Radoslav GajaninInstitute of Pathology, University Clinical Center of Republic of Srpska, School of Medicine, University of Banja Luka, 12 Beba St, 78000 Banja Luka, Bosnia and Herzegovina.
Zoran MilovanovićSpecial Police Unit, Police Department of the City of Belgrade, Ministry of Interior, Trebevićka 12/A, 11030 Belgrade, Serbia.
Eugenie NepovimovaDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanského 62, 500 03 Hradec Králové, Czech Republic.
Kamil KučaDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanského 62, 500 03 Hradec Králové, Czech Republic.ORCID 0000-0001-9664-1109
Vesna JaćevićDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanského 62, 500 03 Hradec Králové, Czech Republic.ORCID 0000-0001-5137-2638
University of Banja Luka · BAMilitary Medical Academy · RSMinistry of Interior of the Republic of Serbia · RSUniversity Hospital Hradec Králové · CZUniversity of Hradec Králové · CZ

Funding

Medical Faculty of the Military Medical Academy, the University of Defence in Belgrade, Republic of Serbia MFVMA/04/20-22UHK Faculty of Science VT2019-2021
6 · The paper itself

Abstract

Increasing evidence suggests that apoptosis of tubular cells and renal inflammation mainly determine the outcome of sepsis-associated acute kidney injury (AKI). The study aim was to investigate the molecular mechanism involved in the renoprotective effects of simvastatin in endotoxin (lipopolysaccharide, LSP)-induced AKI. A sepsis model was established by intraperitoneal injection of a single non-lethal LPS dose after short-term simvastatin pretreatment. The severity of the inflammatory injury was expressed as renal damage scores (RDS). Apoptosis of tubular cells was detected by Terminal deoxynucleotidyl transferase-mediated dUTP Nick End Labeling (TUNEL assay) (apoptotic DNA fragmentation, expressed as an apoptotic index, AI) and immunohistochemical staining for cleaved caspase-3, cytochrome C, and anti-apoptotic Bcl-xL and survivin. We found that endotoxin induced severe renal inflammatory injury (RDS = 3.58 ± 0.50), whereas simvastatin dose-dependently prevented structural changes induced by LPS. Furthermore, simvastatin 40 mg/kg most profoundly attenuated tubular apoptosis, determined as a decrease of cytochrome C, caspase-3 expression, and AIs (

Indexed as

Acute Kidney InjuryAnimalsApoptosisbcl-X ProteinCell SurvivalCytochromes cEndotoxinsEpithelial CellsHumansInflammationKidneyKidney TubulesLipopolysaccharidesRatsSimvastatinbcl-X ProteinCytochromes cEndotoxinsLipopolysaccharidesSimvastatinBcl-XLcytochrome Cendotoxinsimvastatinsurvivintubular apoptosis

Identifiers

PMID33008033
PMCPMC7583796
OpenAlexW3091332987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.